Virginia Marijuana Laws: Possession, Cultivation, and Legal Status Guide

Executive Summary

Virginia's marijuana laws exist in a state of legal uncertainty following a July 2026 budget amendment that prosecutors argue may have accidentally repealed key criminal penalties for cannabis possession and distribution. The Commonwealth legalized simple possession of up to one ounce of marijuana for adults 21 and older in July 2021 under House Bill 2312, but delayed the creation of a regulated commercial market. Virginia currently operates under a hybrid framework where possession is legal but sales remain prohibited, creating what advocates call a "legal limbo." The state permits home cultivation of up to four plants per household and allows medical marijuana dispensaries to operate under a separate regulatory structure established in 2020. As of July 2026, Virginia has not launched adult-use retail sales, making it an outlier among states that have legalized possession. The recent budget language controversy centers on whether technical amendments to Title 18.2 of the Virginia Code inadvertently removed criminal penalties for marijuana offenses, potentially creating a window where enforcement has become legally questionable. This development affects approximately 8.6 million Virginia residents and has significant implications for the state's criminal justice system, pending prosecutions, and the timeline for establishing a regulated cannabis market.

Why This Matters

The legal ambiguity surrounding Virginia marijuana laws affects criminal defendants, law enforcement agencies, medical patients, potential business operators, and state revenue projections. Virginia arrested approximately 18,500 individuals for marijuana-related offenses in 2020, the year before legalization, according to Virginia State Police data. While simple possession arrests have declined dramatically since 2021, distribution and cultivation charges continue, with prosecutors pursuing approximately 3,200 marijuana-related cases annually as of 2025. The medical cannabis program serves over 47,000 registered patients as of June 2026, according to the Virginia Board of Pharmacy. These patients rely on five licensed pharmaceutical processors operating eight dispensary locations statewide. Any legal uncertainty threatens continuity of access for patients treating conditions including cancer, epilepsy, post-traumatic stress disorder, and chronic pain. The delayed commercial market represents substantial lost tax revenue. The Joint Legislative Audit and Review Commission projected that a fully operational adult-use market would generate between $154 million and $308 million in annual tax revenue by 2024. Virginia's failure to launch retail sales means the Commonwealth has forgone an estimated $400 million in cumulative tax revenue since 2021, funds earmarked for education, substance abuse treatment, and social equity programs. Business operators face continued uncertainty about licensing timelines and regulatory requirements. The Virginia Cannabis Control Authority received over 500 preliminary applications for cultivation, manufacturing, and retail licenses before pausing the process in 2023 due to legislative gridlock. These applicants represent millions of dollars in sunk costs for real estate, legal fees, and business planning with no clear path to market entry.

Background and History

Virginia's path to marijuana legalization spans two decades of incremental policy changes, from decriminalization to medical access to adult-use legalization without a functioning retail market.

Early Decriminalization Efforts (2004-2019)

Virginia first reduced penalties for marijuana possession in 2004 when the General Assembly lowered the maximum jail sentence for first-time possession from 12 months to 30 days. The state maintained marijuana as a Schedule I controlled substance under Virginia Code § 54.1-3446, alongside heroin and LSD. In 2020, the General Assembly passed House Bill 972 and Senate Bill 2, decriminalizing simple possession of marijuana. Governor Ralph Northam signed the legislation on April 12, 2020, making possession of up to one ounce a civil violation punishable by a $25 fine rather than a criminal misdemeanor. The law took effect July 1, 2020, and eliminated jail time for first-time possession offenses.

Medical Cannabis Framework (2015-2021)

Virginia established a limited medical cannabis program in 2015 through Senate Bill 1235, which allowed affirmative defense for possession of cannabidiol oil or THC-A oil for treatment of intractable epilepsy. The law required a written certification from a physician but created no legal mechanism for patients to obtain the medicine. The General Assembly expanded medical access substantially in 2018 through House Bill 1251 and Senate Bill 726. These bills authorized five pharmaceutical processors to cultivate, process, and dispense cannabis products to patients with written certifications. The Board of Pharmacy issued licenses to Columbia Care (Portsmouth), Dharma Pharmaceuticals (Bristol), gLeaf Medical (Richmond), Green Leaf Medical (Manassas), and PharmaCann (Staunton). The first medical dispensary opened in March 2020 in Richmond. By December 2020, all five processors had operational dispensaries. The General Assembly expanded qualifying conditions in 2020 to include any condition for which a practitioner issues a written certification, effectively creating a broad medical access program.

Adult-Use Legalization (2021)

On April 7, 2021, Governor Northam signed House Bill 2312 and Senate Bill 1406, making Virginia the first Southern state to legalize adult-use marijuana. The legislation legalized possession of up to one ounce of marijuana for adults 21 and older, effective July 1, 2021. The law also permitted home cultivation of up to four plants per household, with a maximum of two mature plants. The legislation established a complex timeline for commercial sales. The bills created the Virginia Cannabis Control Authority to regulate the adult-use market and directed the agency to begin accepting license applications no later than July 1, 2023, with retail sales projected to begin in 2024. Key provisions of the 2021 legalization included:

• Legalization of possession up to one ounce for adults 21+
• Home cultivation of up to four plants per household
• Automatic sealing of prior marijuana possession convictions
• 30% of tax revenue allocated to Pre-K programs
• 40% to substance abuse treatment and education
• 30% to Cannabis Equity Reinvestment Fund for communities disproportionately impacted by enforcement

Implementation Delays and Political Gridlock (2022-2025)

The Virginia Cannabis Control Authority began operations in 2022 but faced immediate challenges. The General Assembly failed to pass enabling legislation in the 2022 session to establish tax rates, license types, and regulatory details necessary for commercial sales. Republican Governor Glenn Youngkin, who took office in January 2022, opposed commercial marijuana sales and declined to support legislation advancing the retail market. In the 2023 session, competing bills from the House and Senate failed to reach consensus on key issues including license allocation, social equity provisions, and the role of existing medical operators. The 2024 General Assembly session saw renewed efforts to establish the commercial market. House Bill 698 and Senate Bill 448 proposed different frameworks for licensing and taxation. The House bill prioritized existing medical operators and limited initial licenses to 50 retail locations. The Senate bill created a lottery system for 400 licenses with enhanced social equity provisions. Neither bill advanced to a floor vote. By 2025, Virginia remained the only state to have legalized possession without establishing a legal purchase mechanism. Advocates criticized the situation as creating a "prohibition by delay" that perpetuated illegal markets and denied the state tax revenue.

The 2026 Budget Amendment Controversy

On June 30, 2026, Governor Youngkin signed the biennial state budget containing technical amendments to Title 18.2 of the Virginia Code. The amendments, buried in a 1,200-page appropriations bill, revised language in sections addressing controlled substances penalties. According to prosecutors in Norfolk and Virginia Beach, the revised language may have inadvertently removed marijuana from the list of substances subject to distribution and manufacturing penalties under Virginia Code § 18.2-248. The Virginia Association of Commonwealth's Attorneys issued a statement on July 7, 2026, requesting clarification from the Attorney General's office. The association noted that the budget language appeared to create a gap in enforcement authority for marijuana offenses beyond simple possession. Defense attorneys in multiple jurisdictions filed motions to dismiss pending marijuana distribution cases based on the alleged repeal.

Key Players

Virginia Cannabis Control Authority

The Virginia Cannabis Control Authority oversees both medical and adult-use cannabis regulation in Virginia. Created by the 2021 legalization legislation, the CCA operates as an independent agency within the executive branch. The authority is governed by a five-member board appointed by the Governor and confirmed by the General Assembly. As of July 2026, the CCA has 47 employees and an annual budget of $8.2 million funded through medical dispensary fees. Executive Director Aaron Bowles, appointed in January 2023, previously served as deputy director of the Washington State Liquor and Cannabis Board. The CCA has published draft regulations for adult-use cultivation, manufacturing, retail, and testing but cannot implement them without legislative authorization to begin licensing.

Virginia Board of Pharmacy

The Virginia Board of Pharmacy regulates the medical cannabis program under Virginia Code § 54.1-3442.6. The board issues pharmaceutical processor licenses, oversees dispensary operations, and maintains the patient registry. The board has approved over 47,000 patient registrations and 1,200 practitioner certifications as of June 2026.

Pharmaceutical Processors

Five companies hold pharmaceutical processor licenses in Virginia: Columbia Care operates a cultivation facility and dispensary in Portsmouth. The company reported serving approximately 11,000 patients in 2025 with annual revenue of $24 million. Columbia Care offers flower, vaporizer cartridges, tinctures, and edibles. Dharma Pharmaceuticals operates in Bristol, serving Southwest Virginia. The company focuses on high-CBD products and reported 6,800 patients in 2025. gLeaf Medical operates in Richmond with a 40,000-square-foot cultivation facility. The company serves approximately 9,500 patients and reported $19 million in 2025 revenue. Green Leaf Medical operates in Manassas, serving Northern Virginia. The company reported 13,200 patients in 2025, the largest patient base among the five processors. PharmaCann operates in Staunton, serving the Shenandoah Valley and Central Virginia. The company serves approximately 6,500 patients.

Advocacy Organizations

Virginia NORML leads advocacy efforts for marijuana law reform in the Commonwealth. The organization, led by Executive Director Jenn Michelle Pedini, coordinated grassroots support for the 2021 legalization legislation and continues to push for implementation of commercial sales. Virginia NORML organized a rally at the State Capitol in March 2026 that drew approximately 800 participants demanding action on retail licensing. The Cannabis Equity Coalition of Virginia focuses on social equity provisions and expungement of prior convictions. The coalition, founded in 2020, advocates for prioritizing license allocation to individuals from communities disproportionately impacted by marijuana enforcement.

Law Enforcement

The Virginia Association of Chiefs of Police opposed the 2021 legalization legislation and continues to express concerns about impaired driving and youth access. The association supported legislation in 2023 to establish per se THC limits for driving under the influence, but the bill failed in committee. The Virginia State Police reported a 73% decline in marijuana possession arrests between 2020 and 2022, from 18,500 to 4,900 arrests. The remaining arrests primarily involve possession over one ounce or possession by individuals under 21.

Legal and Regulatory Framework

Virginia marijuana laws create a complex patchwork of permitted and prohibited conduct under state statutes, with federal prohibition under the Controlled Substances Act remaining in effect.

Current Legal Possession Limits

Under Virginia Code § 4.1-601, adults 21 and older may legally possess up to one ounce of marijuana. Possession of more than one ounce but less than one pound is a misdemeanor punishable by up to 12 months in jail and a $2,500 fine. Possession of one pound or more is a felony under Virginia Code § 18.2-248.1, punishable by up to 10 years in prison. Individuals under 21 who possess marijuana face civil penalties: a $25 fine and mandatory substance abuse education for a first offense, a $25 fine and 50 hours of community service for a second offense, and a $25 fine and loss of driving privileges for six months for a third offense.

Home Cultivation Provisions

Virginia Code § 4.1-600 permits adults 21 and older to cultivate up to four marijuana plants per household, with a maximum of two mature plants. Plants must be cultivated in a location not visible from public view and reasonably secure from access by individuals under 21. Cultivation of more than four plants is a misdemeanor for a first offense and a felony for subsequent offenses. The law does not require registration or notification of home cultivation. Landlords may prohibit cultivation in rental properties through lease agreements. Local governments may not prohibit home cultivation but may regulate the location through zoning ordinances.

Public Consumption Restrictions

Virginia Code § 4.1-600 prohibits consumption of marijuana in any public place. Public place is defined as any location open to the public, including streets, sidewalks, parks, restaurants, and businesses. Violation is a civil penalty of $25. The law also prohibits consumption in a motor vehicle, whether the vehicle is in motion or parked. Violation is a Class 4 misdemeanor punishable by a $250 fine.

Distribution and Sales Prohibitions

Virginia law prohibits all sales, distribution, and gifting of marijuana outside the licensed medical cannabis program. Virginia Code § 18.2-248.1 makes distribution of marijuana a felony punishable by five to 40 years in prison, depending on the quantity. Distribution of more than one ounce but less than five pounds carries a sentence of five to 30 years. Distribution of five pounds or more carries a sentence of five to 40 years. The statute makes no exception for non-commercial transfers between adults. Gifting marijuana, even without compensation, constitutes distribution under Virginia law. This prohibition has led to the emergence of "gifting" businesses that sell merchandise or services and "gift" marijuana with the purchase, a model that law enforcement considers illegal distribution.

Medical Cannabis Regulations

The medical cannabis program operates under separate regulations in Virginia Code § 54.1-3442.6 and Virginia Administrative Code 18VAC110-60. Patients must obtain a written certification from a registered practitioner. There is no registration fee for patients, and certifications are valid for one year. Medical cannabis products may contain any ratio of THC to CBD, with no potency limits. Pharmaceutical processors may dispense flower, vaporizer cartridges, tinctures, topicals, edibles, and other formulations. Patients may possess up to a 90-day supply as determined by their certifying practitioner. Medical cannabis patients may not cultivate marijuana at home. The law provides no reciprocity for out-of-state medical cannabis cards.

Employment and Housing Protections

Virginia law provides limited protections for marijuana use. Employers may prohibit marijuana use and may terminate employees who test positive for THC. The 2021 legalization legislation included no employment protections for off-duty use. Landlords may prohibit marijuana use and cultivation in rental properties through lease agreements. Public housing authorities, governed by federal law, prohibit marijuana use and possession in federally subsidized housing.

Federal Law Conflicts

Marijuana remains a Schedule I controlled substance under the Controlled Substances Act, 21 U.S.C. § 812. Federal law prohibits cultivation, possession, and distribution of marijuana regardless of state law. The Rohrabacher-Farr Amendment, renewed annually since 2014, prohibits the Department of Justice from using funds to interfere with state medical cannabis programs, but provides no protection for adult-use programs. Federal prohibition creates barriers for Virginia's cannabis industry. Banks and credit unions, regulated by federal agencies, largely refuse to serve cannabis businesses. Marijuana businesses cannot deduct ordinary business expenses under Internal Revenue Code § 280E, which prohibits deductions for businesses trafficking in controlled substances.

State-by-State Context

Virginia's approach to marijuana legalization—permitting possession while indefinitely delaying commercial sales—is unique among the 24 states that have legalized adult-use cannabis.

Neighboring State Comparisons

Maryland legalized adult-use marijuana through a ballot initiative in November 2022, with sales beginning July 1, 2023. Maryland permits possession of up to 1.5 ounces and home cultivation of two plants. The state issued 100 retail licenses in the first year, generating $200 million in sales and $40 million in tax revenue in the first six months. Washington D.C. legalized possession and home cultivation through Initiative 71 in 2015, but Congress has blocked the District from implementing commercial sales through annual appropriations riders. D.C. permits possession of up to two ounces and cultivation of six plants. The District's "gifting economy" operates in a legal gray area similar to Virginia's current situation. North Carolina has not legalized marijuana but decriminalized possession of up to 0.5 ounces in 2021. Possession remains a misdemeanor with a maximum $200 fine. Medical cannabis legislation has been introduced in multiple sessions but has not advanced. West Virginia operates a medical cannabis program established in 2017, with dispensaries opening in 2021. The state has not decriminalized or legalized adult-use marijuana. Possession remains a misdemeanor punishable by up to six months in jail. Kentucky legalized medical cannabis in 2023 through House Bill 829, with dispensaries projected to open in 2025. Adult-use marijuana remains illegal, with possession of any amount a misdemeanor. Tennessee maintains full prohibition of marijuana, with possession of any amount a misdemeanor punishable by up to one year in jail. Medical cannabis legislation has been introduced but has not advanced.

Market and Business Implications

Virginia's delayed commercial market has created a multi-billion-dollar opportunity that remains inaccessible to legal businesses while illegal operators fill the void.

Market Size Projections

The Joint Legislative Audit and Review Commission estimated Virginia's adult-use cannabis market would reach $700 million in annual sales by 2024, growing to $1.2 billion by 2028. These projections assumed retail sales beginning in 2024. The delay has allowed illegal market operators to capture revenue that would otherwise flow to licensed businesses and generate tax revenue for the Commonwealth. Virginia's population of 8.6 million and median household income of $80,900 position the state as one of the most lucrative untapped cannabis markets in the United States. Neighboring Maryland, with a population of 6.2 million, generated $1.4 billion in cannabis sales in 2024, its first full year of adult-use sales.

Medical Market Performance

Virginia's five pharmaceutical processors reported combined revenue of approximately $95 million in 2025, according to Virginia Cannabis Control Authority data. This represents a 28% increase from 2024 revenue of $74 million. The medical market has grown steadily since dispensaries opened in 2020, but growth has plateaued as the patient base approaches saturation. Average transaction size in Virginia's medical program is $87, with patients making an average of 11 purchases per year. The most popular product categories are flower (42% of sales), vaporizer cartridges (31%), and tinctures (15%).

License Application Backlog

The Virginia Cannabis Control Authority received 544 preliminary applications for adult-use licenses before pausing the process in 2023. Applications included 187 for cultivation licenses, 142 for manufacturing licenses, 198 for retail licenses, and 17 for testing laboratory licenses. Applicants paid non-refundable fees ranging from $1,000 to $5,000 per application. Many applicants have invested substantially more in business planning, real estate deposits, and legal fees. Industry attorneys estimate that applicants have collectively invested over $50 million in preparation for a market that has not materialized.

Social Equity Provisions

The 2021 legalization legislation included social equity provisions designed to prioritize license allocation to individuals from communities disproportionately impacted by marijuana enforcement. The Cannabis Equity Reinvestment Fund, capitalized with 30% of projected tax revenue, was intended to provide grants and loans to social equity applicants. The fund has received no revenue because commercial sales have not begun. The General Assembly appropriated $4 million in seed funding in 2022, but the Cannabis Control Authority has not distributed grants pending finalization of licensing regulations. Social equity criteria include residence in a historically over-policed census tract, prior marijuana conviction, or household income below 400% of federal poverty level. The legislation directed the CCA to reserve at least 30% of licenses for social equity applicants, but implementation details remain unresolved.

Impact on Multi-State Operators

Several multi-state operators hold pharmaceutical processor licenses in Virginia and are positioned to enter the adult-use market when licensing begins. Columbia Care, acquired by Cresco Labs in 2022, operates in 18 states. PharmaCann operates in eight states. These companies have the capital and operational expertise to scale rapidly once adult-use sales are permitted. The delay in Virginia's market has forced MSOs to redirect capital to other states with clearer regulatory timelines. Cresco Labs reported in its 2025 annual report that Virginia represented less than 2% of company revenue, down from projections of 8-10% if the adult-use market had launched as scheduled.

Banking and Financial Services Challenges

Virginia cannabis businesses face the same banking challenges as operators in other states. Most banks refuse to provide services to cannabis businesses due to federal prohibition and anti-money laundering regulations. The five pharmaceutical processors operate primarily in cash, creating security risks and operational inefficiencies. The SAFER Banking Act, which would provide safe harbor for financial institutions serving state-legal cannabis businesses, passed the House in 2023 but has not advanced in the Senate. Until federal banking protections are enacted, Virginia cannabis businesses will face limited access to capital and financial services.

What Experts Say

Legal scholars, industry analysts, and policy advocates have offered varied perspectives on Virginia's marijuana law implementation and the recent budget controversy. Jenn Michelle Pedini, executive director of Virginia NORML, described the situation as "a policy failure that harms Virginians and enriches illegal operators" in a July 2026 statement. Pedini noted that the lack of legal sales forces consumers to choose between home cultivation, medical certification, or illegal purchases. Rachel Gillette, executive director of the Cannabis Equity Coalition of Virginia, emphasized the social justice implications of the delay. According to Gillette, Black Virginians were 3.5 times more likely to be arrested for marijuana possession than white Virginians in 2019, despite similar usage rates. Gillette stated that continued enforcement of distribution laws perpetuates racial disparities in the criminal justice system. Robert Mikos, professor at Vanderbilt Law School and author of "Marijuana Law, Policy, and Authority," analyzed Virginia's legal framework in a 2025 law review article. According to Mikos, Virginia's approach creates a "legalization without commercialization" model that is legally coherent but practically unworkable. Mikos noted that the model assumes consumers will either cultivate at home or abstain, ignoring market realities. Regarding the 2026 budget controversy, University of Virginia law professor Richard Schragger told the Virginia Mercury that the language appears to be a drafting error rather than intentional policy change. According to Schragger, courts are likely to interpret the statute to preserve legislative intent, but the ambiguity creates legitimate questions about prosecutorial authority in the interim. Beau Kilmer, director of the RAND Drug Policy Research Center, compared Virginia's situation to Washington D.C.'s experience with congressional interference. According to Kilmer, both jurisdictions demonstrate the challenges of partial legalization. Kilmer's research found that D.C.'s gifting market operates with minimal regulatory oversight and generates no tax revenue, outcomes Virginia risks replicating. Industry analyst Vivien Azer of Cowen & Company estimated that Virginia's delay has cost the state approximately $400 million in foregone tax revenue between 2021 and 2026. Azer noted that neighboring Maryland captured market share from Virginia consumers willing to travel across state lines for legal purchases.

What's Next

Virginia's marijuana policy faces several decision points in the coming months that will determine whether the Commonwealth moves toward a regulated market or continues its current stalemate.

Attorney General Opinion on Budget Language

The Virginia Association of Commonwealth's Attorneys requested a formal opinion from Attorney General Jason Miyares on July 7, 2026, regarding whether the budget amendments inadvertently repealed marijuana distribution penalties. The Attorney General's office typically issues opinions within 60 to 90 days of a request. An opinion finding that penalties were repealed would likely trigger emergency legislation in a special session to restore enforcement authority. Defense attorneys have filed motions to dismiss in approximately 40 pending marijuana distribution cases across multiple jurisdictions as of July 8, 2026. Circuit courts are expected to rule on these motions in August and September 2026. Conflicting rulings from different jurisdictions could create a split of authority requiring Virginia Supreme Court resolution.

2027 General Assembly Session

The 2027 General Assembly session, convening in January, represents the next opportunity for comprehensive marijuana legislation. Advocates are pressing for bills to authorize the Cannabis Control Authority to begin licensing and establish tax rates and regulatory details for the adult-use market. Political dynamics will influence legislative prospects. The House of Delegates has a narrow Republican majority, while the Senate has a narrow Democratic majority. Governor Youngkin, whose term ends in January 2026, has signaled opposition to commercial sales but has not threatened to veto legislation if passed by both chambers. Key issues requiring resolution include:

• Number and types of licenses to be issued
• Tax rate structure (excise tax, sales tax, or both)
• Social equity provisions and license allocation methodology
• Role of existing medical operators in the adult-use market
• Local government authority to prohibit retail sales
• Potency limits and product restrictions
• Impaired driving enforcement and per se THC limits

Federal Rescheduling Proceedings

The Drug Enforcement Administration published a Notice of Proposed Rulemaking in May 2024 to reschedule marijuana from Schedule I to Schedule III under the Controlled Substances Act. The DEA held administrative law judge hearings in late 2024 and early 2025. A final rule is expected in late 2026 or early 2027. Rescheduling to Schedule III would not legalize marijuana under federal law but would eliminate the application of Internal Revenue Code § 280E to cannabis businesses. This change would significantly improve profitability for Virginia's pharmaceutical processors and future adult-use operators by allowing normal business expense deductions.

Potential Ballot Initiative

Virginia does not have a citizen initiative process, so voters cannot directly place marijuana measures on the ballot. All policy changes must go through the General Assembly. However, advocates have discussed pursuing a constitutional amendment to establish a citizen initiative process, which would require approval by two successive General Assembly sessions and a statewide referendum.

Litigation Scenarios

If the Attorney General concludes that the budget language did not repeal marijuana penalties, defense attorneys may file constitutional challenges arguing that the ambiguity violates due process rights. The Virginia Supreme Court has not ruled on marijuana legalization issues since the 2021 law took effect. Alternatively, if courts find that penalties were repealed, prosecutors may argue that distribution remains prosecutable under general drug trafficking statutes or conspiracy laws. This scenario would create legal uncertainty requiring appellate resolution.

Further Reading

• Virginia Code § 4.1-600 et seq. (marijuana legalization statutes): https://law.lis.virginia.gov/vacode/title4.1/chapter6/
• Virginia Code § 54.1-3442.6 (pharmaceutical processor licensing): https://law.lis.virginia.gov/vacode/title54.1/chapter34/section54.1-3442.6/
• Virginia Code § 18.2-248.1 (marijuana distribution penalties): https://law.lis.virginia.gov/vacode/title18.2/chapter7/section18.2-248.1/
• Virginia Cannabis Control Authority official website: https://www.cca.virginia.gov/
• Virginia Board of Pharmacy medical cannabis program information: https://www.dhp.virginia.gov/pharmacy/cannabisoil/
• Joint Legislative Audit and Review Commission report on marijuana legalization (2020): http://jlarc.virginia.gov/marijuana.asp
• House Bill 2312 (2021 legalization legislation) full text: https://lis.virginia.gov/cgi-bin/legp604.exe?211+ful+HB2312
• Virginia NORML advocacy resources: https://www.vanorml.org/
• RAND Corporation research on marijuana policy: https://www.rand.org/topics/marijuana.html
• Drug Enforcement Administration marijuana rescheduling docket: https://www.regulations.gov/docket/DEA-2024-0059

Update — July 12, 2026: Budget Language Briefly Threw Marijuana Laws Into Question

Confusing language in Virginia's 2026-2028 biennial budget temporarily raised questions about the state's marijuana possession laws in early July 2026. The budget bill included a provision that appeared to contradict existing statutes allowing adults 21 and older to possess up to one ounce of cannabis, according to legislative analysts who flagged the discrepancy during routine review.

The problematic section referenced outdated criminal penalties for simple possession that had been effectively nullified by the 2021 legalization of adult-use possession. State lawmakers said the language was a drafting error that inadvertently carried forward pre-2021 statutory text into the appropriations measure. No enforcement actions were taken during the roughly 48-hour period between budget passage and clarification, and the Virginia Attorney General's office issued guidance confirming that possession limits remained unchanged.

Legislative counsel issued a technical correction on July 10, 2026, striking the conflicting language and reaffirming that adults may lawfully possess up to one ounce without penalty. The incident highlighted ongoing challenges in reconciling Virginia's patchwork marijuana framework, which legalized possession in 2021 but delayed retail sales indefinitely. Advocacy groups used the confusion to renew calls for comprehensive statutory reform that would consolidate all cannabis provisions into a single, coherent code section.

The error had no practical impact on consumers or law enforcement, but it underscored the legal ambiguity that persists in Virginia's cannabis landscape. Operators awaiting retail licensing guidance said the episode reinforced concerns about regulatory clarity as the state continues debating whether and when to authorize commercial sales beyond the existing medical program.